Slaughter and May, Cleary Gottlieb Steen & Hamilton and Bowman Gilfillan advised GlaxoSmithKline (GSK) on the sale of its remaining 6.2% stake in Aspen Pharmacare, announced last week.
Continue reading “South African sell-down: Slaughters leads as GSK exits Aspen Pharmacare”
